HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bayer Spreads Aleve Brand Into Topical Pain Relief

AleveX Ad Campaign Featuring Charles Barkley Links Golf With Pain

Executive Summary

Three-product AleveX line contains menthol and camphor for minor muscle and joints aches and pains with a cooling sensation. Bayer Healthcare promotes launch with an ad campaign featuring basketball legend and TV personality Charles Barkley.

You may also be interested in...



Bayer Beats The Market In 2021 And Has High Hopes For 2022

Bayer Consumer Health posted sales up 6.5% in 2021 as strong demand for supplements and successful launches helped it grow faster than the global market. The company believes it can deliver up to 5% sales growth in 2022 driven by the upcoming launch of Astepro Allergy in the US and the return of the cough & cold category.

Successful Innovation And Supplement Gains Drive 'Exceptional' Q3 For Bayer

Successful launches and increased demand for dietary supplements helped to drive up Bayer's Consumer Health's sales double-digits in Q3. As a consequence, the German firm has raised its 2021 sales guidance for Consumer Health for the second time so far this year.

Bayer Raises Consumer Health Guidance Following Double-Digit Gain In Q2

Bayer believes its Consumer Health business has the potential to grow at twice the rate of the global market in 2021 following a double-digit rise in sales in the second quarter.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS151624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel